U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse

Reuters04-12

April 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cheesecake Factory, Netflix and Texas Roadhouse, on Friday.

HIGHLIGHTS

* Cheesecake Factory Inc : Stephens resumes coverage with

overweight rating

* Netflix Inc : Piper Sandler raises target price to $600 from

$550

* Texas Roadhouse Inc : Stephens resumes coverage with

equal-weight rating

Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.

* Alpine Immune Sciences : Leerink Partners cuts to market perform from

outperform

* Alpine Immune Sciences : Leerink Partners raises target price to $65

from $42

* Boeing : JP Morgan cuts target price to $210 from $230

* Caremax Inc : Jefferies cuts target price to $3 from $7.5

* Century Therapeutics Inc : Piper Sandler cuts target price to $9 from

$10

* Cheesecake Factory Inc : Stephens resumes coverage with overweight

rating

* Cheesecake Factory Inc : Stephens resumes coverage with target price

$44

* Chipotle Mexican Grill Inc : Stephens resumes coverage with

equal-weight rating

* Chipotle Mexican Grill Inc : Stephens resumes coverage with target

price $3010

* Chord Energy Corp : Gerdes Energy Research cuts to neutral from buy

* Chord Energy Corp : Gerdes Energy Research raises target price by $2

to $205

* Chuy's Holdings Inc : Stephens resumes coverage with overweight rating

* Chuy's Holdings Inc : Stephens resumes coverage with target price $40

* Darden Restaurants Inc : Stephens resumes coverage with equal-weight

rating

* Darden Restaurants Inc : Stephens resumes coverage with target price

$170

* Delta Air Lines Inc : TD Cowen raises target price to $55 from $49

* Domino's Pizza Inc : Stephens resumes coverage with equal-weight rating

* Domino's Pizza Inc : Stephens resumes coverage with target price $479

* Dynatrace Inc : Jefferies cuts target price to $60 from $70

* Enliven Therapeutics Inc : Jefferies raises target price to $32 from

$26

* Fastenal Co : Stephens raises target price to $69 from $63

* Instil Bio Inc : Jefferies cuts to hold from buy

* Instil Bio Inc : Jefferies raises target price to $11 from $5

* Meta : Wedbush raises target price to $570 from $520

* Mondelez : JP Morgan cuts target price to $76 from $82

* Netflix Inc : Piper Sandler raises target price to $600 from $550

* One Group Hospitality Inc : Stephens resumes coverage with overweight

rating

* One Group Hospitality Inc : Stephens resumes coverage with target

price $9

* Ovintiv Inc : Jefferies raises target price to $69 from $59

* Papa John's International Inc : Stephens resumes coverage with

overweight rating

* Papa John's International Inc : Stephens resumes coverage with target

price $75

* PMV Pharmaceuticals Inc : Jefferies initiates coverage With Buy rating

* PMV Pharmaceuticals Inc : Jefferies initiates coverage With target

price $5

* Regeneron Pharmaceuticals Inc : Jefferies raises PT to $1,060 from

$1,025

* Rent the Runway Inc : Jefferies cuts target price to $21 from $53

* Revolution Medicines Inc : Oppenheimer raises target price to $45 from

$43

* RTX Corp : Jefferies raises target price to $105 from $100

* Texas Roadhouse Inc : Stephens resumes coverage with equal-weight

rating

* Texas Roadhouse Inc : Stephens resumes coverage with target price $150

* Tilray Brands Inc : Jefferies cuts target price to $3.13 from $4.1

* Wendys Co : Stephens resumes coverage with equal-weight rating; target

price $20

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment